The technology of three dimensional(3D) printing,also known as additive manufacturing,is a cuttingedge type of fabrication method that utilizes a computer-aided design platform and employs layer-bylayer stacking to co...The technology of three dimensional(3D) printing,also known as additive manufacturing,is a cuttingedge type of fabrication method that utilizes a computer-aided design platform and employs layer-bylayer stacking to construct objects with exceptional flexibility.Due to its capacity to produce a substantial quantity of products within a short period of time,3D printing has emerged as one of the most significant manufacturing technology.Over the past two decades,remarkable advancements have been made in the application of 3D printing technology in the realm of bone tissue engineering.This review presents an innovative and systematic discussion on the potential application of 3D printing technology in bone tissue engineering,particularly in the treatment of infected bone defects.It comprehensively evaluates the materials utilized in 3D printing,highlights the interplay between cells and bone regeneration,and addresses and resolves challenges associated with current 3D printing technology.These challenges include material selection,fabrication of intricate 3D structures,integration of different cell types,streamlining design processes and material selection procedures,enhancing the clinical translational potential of 3D printing technology,and ultimately exploring future applications of four dimensional(4D) printing technology.The 3D printing technology has demonstrated significant potential in the synthesis of bone substitutes,offering consistent mechanical properties and ease of use.It has found extensive applications in personalized implant customization,prosthetic limb manufacturing,surgical tool production,tissue engineering,biological modeling,and cell diagnostics.Simultaneously,3D bioprinting provides an effective solution to address the issue of organ donor shortage.However,challenges still exist in material selection,management of structural complexity,integration of different cell types,and construction of functionally mature tissues.With advancements in multi-material printing techniques as well as bioprinting and 4D printing technologies emerging on the horizon;3D printing holds immense prospects for revolutionizing the means by which infectious bone defects are repaired.展开更多
Objective: To systematically evaluate the clinical efficacy and safety of Masquelet technology and Llizarov group technology in the treatment of infectious bone defects by meta-analysis. Methods: The computer searched...Objective: To systematically evaluate the clinical efficacy and safety of Masquelet technology and Llizarov group technology in the treatment of infectious bone defects by meta-analysis. Methods: The computer searched China Knowledge Network (CNKI), Wanfang, VIP, Chinese Biomedical Literature Database (CBM), Pubmed, Medline, Cochrane Llibrary databases. The retrieval time was from the time of the establishment of the database to January 2020. According to the inclusion and exclusion criteria, randomized controlled trials on the treatment of infectious bone defects using Masquelet technology and Llizarov technology were collected, and the retrieved literature was independently screened, evaluated, and data extracted by two researchers, and then RevMan5.3 software was used so for meta-analysis. Results: A total of 10 RCT documents were included, with a total of 496 patients, including 242 in the Masquelet group and 254 in the Llizarov group. The results of the meta-analysis showed that: in terms of bone defect healing time, total weight bearing time, treatment cost, and complication rate, the Masquelet group was significantly different from the Llizarov group, and the Masquelet group was better than the Llizarov group (P <0.05);In terms of knee joint Lowa score and SF-36 score, Masquelet group has significant differences compared with Llizarov group, Llizarov group is better than Masquelet group (P <0.05);in excellent rate, number of operations, ankle Lowa score, infection control rate In terms of excellent rate of affected limb function, there was no significant difference between Masquelet group and Llizarov group (P> 0.05). Conclusion:Compared with Llizarov technology, Masquelet technology has obvious advantages in the treatment of infectious bone defects in terms of bone defect healing time, total weight-bearing time, treatment cost, and complication rate. In terms of scoring, it has advantages over Masquelet technology, but in terms of excellent treatment rate, number of operations, and ankle lowa score. In terms of infection control rate and excellent function of affected limbs, there was no significant difference between Masquelet technology and Llizarov technology,However, due to the low quality of the included studies and the small sample size, the exact efficacy still needs to be confirmed by higher quality RCT studies.展开更多
Addressing the challenge of eliminating bacteria and stimulating osteogenesis in infectious bone defects,where cells and bacteria coexist within the microenvironment,presents a significant hurdle.In this study,a strat...Addressing the challenge of eliminating bacteria and stimulating osteogenesis in infectious bone defects,where cells and bacteria coexist within the microenvironment,presents a significant hurdle.In this study,a strategy of targeting bacteria is proposed to address this challenge.For this purpose,a methacrylated gelatin composite hydrogel containing zinc ion and D-type cysteine-modified polydopamine nanoparticles(PZC)is developed.The D-cysteine,involved in the metabolism of the bacterial peptidoglycan chain,allows PZC to specifically target bacteria,exhibiting a form of“disguise strategy”.Through the targeting effect,this composite hydrogel can selectively kill bacteria and promote osteogenesis combing photothermal therapy with Zn^(2+)release,which showcases spatial controllability.Moreover,the antibacterial ability will be further improved after Near-infrared light irradiation.The multifunctional hydrogel containing Zn^(2+)modified nanoparticles can also promote osteogenic differentiation of bone marrow stem cells.Animal studies have revealed that the multifunctional hydrogel can inhibit bacteria growth and promote repair of infectious bone defects in rats.Findings from this study imply that endowing the nanoparticles with bacteria-targeting function can precisely control the events in cells and bacteria in the complex microenvironment,which can provide insights for the treatment of complex diseases with antibacterial requirements.展开更多
Large bone defects face a high risk of pathogen exposure due to open wounds,which leads to high infection rates and delayed bone union.To promote successful repair of infectious bone defects,fabrication of a scaffold ...Large bone defects face a high risk of pathogen exposure due to open wounds,which leads to high infection rates and delayed bone union.To promote successful repair of infectious bone defects,fabrication of a scaffold with dual functions of osteo-induction and bacterial inhibition is required.This study describes creation of an engineered progenitor cell line(C3H10T1/2)capable of doxycycline(DOX)-mediated release of bone morphogenetic protein-2(BMP2).Three-dimensional bioprinting technology enabled creation of scaffolds,comprising polycaprolactone/mesoporous bioactive glass/DOX and bioink,containing these engineered cells.In vivo and in vitro experiments confirmed that the scaffold could actively secrete BMP2 to significantly promote osteoblast differentiation and induce ectopic bone formation.Additionally,the scaffold exhibited broad-spectrum antibacterial capacity,thereby ensuring the survival of embedded engineered cells when facing high risk of infection.These findings demonstrated the efficacy of this bioprinted scaffold to release BMP2 in a controlled manner and prevent the occurrence of infection;thus,showing its potential for repairing infectious bone defects.展开更多
基金supported by the National Natural Science Fund of China(Nos.82202726,82370929)the National Clinical Research Center for Geriatrics,West China Hospital,Sichuan University(No.Z20192013)+5 种基金Key research and development project of Sichuan Science and Technology Department(No.2023YFG0219)"Zeroto One" Innovation Research Project of Sichuan University(No.2022SCUH0014)Frontiers Medical Center,Tianfu Jincheng Laboratory Foundation(No.TFJC2023010001)Sichuan Science and Technology Program(No.2022NSFSC0002)Sichuan Province Youth Science and Technology Innovation Team(No.2022JDTD0021)Research and Develop Program,West China Hospital of Stomatology Sichuan University(Nos.RD03202302,RCDWJS2024-1)。
文摘The technology of three dimensional(3D) printing,also known as additive manufacturing,is a cuttingedge type of fabrication method that utilizes a computer-aided design platform and employs layer-bylayer stacking to construct objects with exceptional flexibility.Due to its capacity to produce a substantial quantity of products within a short period of time,3D printing has emerged as one of the most significant manufacturing technology.Over the past two decades,remarkable advancements have been made in the application of 3D printing technology in the realm of bone tissue engineering.This review presents an innovative and systematic discussion on the potential application of 3D printing technology in bone tissue engineering,particularly in the treatment of infected bone defects.It comprehensively evaluates the materials utilized in 3D printing,highlights the interplay between cells and bone regeneration,and addresses and resolves challenges associated with current 3D printing technology.These challenges include material selection,fabrication of intricate 3D structures,integration of different cell types,streamlining design processes and material selection procedures,enhancing the clinical translational potential of 3D printing technology,and ultimately exploring future applications of four dimensional(4D) printing technology.The 3D printing technology has demonstrated significant potential in the synthesis of bone substitutes,offering consistent mechanical properties and ease of use.It has found extensive applications in personalized implant customization,prosthetic limb manufacturing,surgical tool production,tissue engineering,biological modeling,and cell diagnostics.Simultaneously,3D bioprinting provides an effective solution to address the issue of organ donor shortage.However,challenges still exist in material selection,management of structural complexity,integration of different cell types,and construction of functionally mature tissues.With advancements in multi-material printing techniques as well as bioprinting and 4D printing technologies emerging on the horizon;3D printing holds immense prospects for revolutionizing the means by which infectious bone defects are repaired.
基金The Science and Technology Project of Henan Province (182102310487)
文摘Objective: To systematically evaluate the clinical efficacy and safety of Masquelet technology and Llizarov group technology in the treatment of infectious bone defects by meta-analysis. Methods: The computer searched China Knowledge Network (CNKI), Wanfang, VIP, Chinese Biomedical Literature Database (CBM), Pubmed, Medline, Cochrane Llibrary databases. The retrieval time was from the time of the establishment of the database to January 2020. According to the inclusion and exclusion criteria, randomized controlled trials on the treatment of infectious bone defects using Masquelet technology and Llizarov technology were collected, and the retrieved literature was independently screened, evaluated, and data extracted by two researchers, and then RevMan5.3 software was used so for meta-analysis. Results: A total of 10 RCT documents were included, with a total of 496 patients, including 242 in the Masquelet group and 254 in the Llizarov group. The results of the meta-analysis showed that: in terms of bone defect healing time, total weight bearing time, treatment cost, and complication rate, the Masquelet group was significantly different from the Llizarov group, and the Masquelet group was better than the Llizarov group (P <0.05);In terms of knee joint Lowa score and SF-36 score, Masquelet group has significant differences compared with Llizarov group, Llizarov group is better than Masquelet group (P <0.05);in excellent rate, number of operations, ankle Lowa score, infection control rate In terms of excellent rate of affected limb function, there was no significant difference between Masquelet group and Llizarov group (P> 0.05). Conclusion:Compared with Llizarov technology, Masquelet technology has obvious advantages in the treatment of infectious bone defects in terms of bone defect healing time, total weight-bearing time, treatment cost, and complication rate. In terms of scoring, it has advantages over Masquelet technology, but in terms of excellent treatment rate, number of operations, and ankle lowa score. In terms of infection control rate and excellent function of affected limbs, there was no significant difference between Masquelet technology and Llizarov technology,However, due to the low quality of the included studies and the small sample size, the exact efficacy still needs to be confirmed by higher quality RCT studies.
基金funding provided for this study by the National Key R&D Program of China(2023YFB3810200,2023YFB3810201)the National Natural Science Foundation of China(81925027,32171350,32471410)+8 种基金International Cooperation Project of Ningbo City(2023H013)Jiangsu Basic Research Program(Natural Science Foundation)(BK20240020)Medical and Health Science and Technology Innovation Project of Suzhou(SKY2022105)Jiangsu Province Science and Technology Plan Special Fund(BE2022730)Postdoctoral Fellowship Program of CPSF(BX20230253,GZB20230505)Basic cutting-edge innovation cross project of Suzhou Medical College of Soochow University(YXY2302010,YXY2304046,YXY2304053)the China Postdoctoral Science Foundation under Grant Number 2023TQ0235Science and Technology Development Project of Suzhou(SGC202379,SZS2023043)the Priority Academic Program Development(PAPD)of Jiangsu Higher Education Institutions.
文摘Addressing the challenge of eliminating bacteria and stimulating osteogenesis in infectious bone defects,where cells and bacteria coexist within the microenvironment,presents a significant hurdle.In this study,a strategy of targeting bacteria is proposed to address this challenge.For this purpose,a methacrylated gelatin composite hydrogel containing zinc ion and D-type cysteine-modified polydopamine nanoparticles(PZC)is developed.The D-cysteine,involved in the metabolism of the bacterial peptidoglycan chain,allows PZC to specifically target bacteria,exhibiting a form of“disguise strategy”.Through the targeting effect,this composite hydrogel can selectively kill bacteria and promote osteogenesis combing photothermal therapy with Zn^(2+)release,which showcases spatial controllability.Moreover,the antibacterial ability will be further improved after Near-infrared light irradiation.The multifunctional hydrogel containing Zn^(2+)modified nanoparticles can also promote osteogenic differentiation of bone marrow stem cells.Animal studies have revealed that the multifunctional hydrogel can inhibit bacteria growth and promote repair of infectious bone defects in rats.Findings from this study imply that endowing the nanoparticles with bacteria-targeting function can precisely control the events in cells and bacteria in the complex microenvironment,which can provide insights for the treatment of complex diseases with antibacterial requirements.
基金supported by the National Key R&D Program(grant no.2016YFC1102100)a NSFC grant(grant no.81921002)the Shanghai Science and Technology Development Fund(grant no.18DZ2291200 and 18441902700).
文摘Large bone defects face a high risk of pathogen exposure due to open wounds,which leads to high infection rates and delayed bone union.To promote successful repair of infectious bone defects,fabrication of a scaffold with dual functions of osteo-induction and bacterial inhibition is required.This study describes creation of an engineered progenitor cell line(C3H10T1/2)capable of doxycycline(DOX)-mediated release of bone morphogenetic protein-2(BMP2).Three-dimensional bioprinting technology enabled creation of scaffolds,comprising polycaprolactone/mesoporous bioactive glass/DOX and bioink,containing these engineered cells.In vivo and in vitro experiments confirmed that the scaffold could actively secrete BMP2 to significantly promote osteoblast differentiation and induce ectopic bone formation.Additionally,the scaffold exhibited broad-spectrum antibacterial capacity,thereby ensuring the survival of embedded engineered cells when facing high risk of infection.These findings demonstrated the efficacy of this bioprinted scaffold to release BMP2 in a controlled manner and prevent the occurrence of infection;thus,showing its potential for repairing infectious bone defects.
